Revagenix Stock

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Sign up today and learn more about Revagenix Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Revagenix Stock

Funding History

January 2020$4.0M

Management

Board Member

Bruce Montgomery

COO

Andrew McCandlish

Board Member

Cristina Larkin

Board Member

Michael Lamprecht

CEO and Acting CSO

Ryan Cirz

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo